secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0001493152-22-036161
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Stephen LaNeve resigns from Bone Biologics board
---------------------------------------------------------

- Stephen LaNeve resigned as a director effective December 18, 2022.
- Resignation was not due to any disagreement with the company's operations, policies, or practices.
- Company expressed appreciation for Mr. LaNeve's years of service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222036161/0001493152-22-036161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315222036161/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-036161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer